Literature DB >> 17723110

Pharmacologic interventions for the management of critical bleeding.

Stacy Voils1.   

Abstract

Hospital pharmacists are often consulted for their knowledge about coagulation and therapeutic interventions for the management of critical bleeding. Many pharmacotherapies are available for this purpose, both systemic and topical, and others are in development. These agents and their mechanisms of action are reviewed, and perspectives are provided regarding their use in various clinical settings. Also provided are associated precautions to promote safe use. Current controversies surrounding pharmacotherapeutic agents used to control serious bleeding (e.g., in various types of surgery, trauma, obstetrics, and intracranial hemorrhage) are also discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17723110     DOI: 10.1592/phco.27.9part2.69S

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Safety and Hemostatic Effectiveness of the Fibrin Pad for Severe Soft-Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic (Non-cardiac) Surgery: A Randomized, Controlled, Superiority Trial.

Authors:  Jonathan Koea; Peter Baldwin; Jessica Shen; B Patel; Jonathan Batiller; Axel Arnaud; James Hart; Jeffrey Hammond; Craig Fischer; O James Garden
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

2.  Fixed-Dose Factor Eight Inhibitor Bypassing Activity (FEIBA) in the Management of Warfarin-Associated Coagulopathies.

Authors:  Francisco Ibarra; Mallory Cruz; Matthew Ford; Meng-Jou Wu
Journal:  Pharmacy (Basel)       Date:  2022-04-23

3.  Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database.

Authors:  Mitra Corral; Nicole Ferko; Sarah Hollmann; Michael S Broder; Eunice Chang
Journal:  Clinicoecon Outcomes Res       Date:  2015-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.